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Objective:We quantify the geometric and hemodynamic characteristics of extracardiac and lateral tunnel Fontan
surgical options and correlate certain anatomic characteristics with their hemodynamic efficiency and patient car-
diac index.
Methods and Results: The study was conducted retrospectively on 22 patients undergoing Fontan operations (11
extracardiac and 11 lateral tunnel operations). Total cavopulmonary connection geometric parameters such as
vessel areas, curvature, and offsets were quantified using a skeletonization method. Energy loss at the total cav-
opulmonary connection junction was available from previous in vitro experiments and computational fluid dy-
namic simulations for 5 and 9 patients, respectively. Cardiac index data were available for all patients. There
was no significant difference in the mean and minimum cross-sectional vessel areas of the pulmonary artery be-
tween the extracardiac and lateral tunnel groups. The indexed energy dissipation within the total cavopulmonary
connection was strongly correlated to minimum cross-sectional area of the pulmonary arteries (R2 value of 0.90
and P< .0002), whereas all other geometric features, including shape characteristics, had no significant correla-
tion. Finally, cardiac index significantly correlated with the minimum pulmonary artery area (P¼ .006), suggest-
ing that total cavopulmonary connection energy losses significantly affect resting cardiac output.
Conclusions: The minimum outlet size of the total cavopulmonary connection (ie, minimum cross section of pul-
monary artery) governs the energy loss characteristics of the total cavopulmonary connection more strongly than
variations in the shapes corresponding to extracardiac and lateral tunnel configurations. Differences in pulmonary
artery sizesmust be accounted forwhen comparing energy losses between extracardiac and lateral tunnel geometries.
Congenital Heart Disease Dasi et alAfter the Fontan procedure,1 the physiology of the resulting
single ventricle circulation is such that the systemic venous
return is routed directly to the lungs for oxygenation via an in
situ surgically fabricated complex two-inlet/two-outlet vas-
cular connection, also known as total cavopulmonary con-
nection (TCPC). The two common variants of the TCPC
are (1) lateral tunnel (LT) and (2) extracardiac (EC)2-4 A pre-
vious study has emphasized the need for lowering the net re-
sistance of the single ventricle circulation5 to help reduce the
secondary complications seen in these patients. Numerous
studies examining the hemodynamic energy efficiency of
the Fontan circulation6-9 have not clearly demonstrated
advantages or disadvantages of one surgical technique
over the other. Furthermore, it has not been demonstrated
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part as of a surgical planning process, would result in a sig-
nificant increase in cardiac output to confer a clinical benefit
to the patient.
Before addressing the significance of geometric variations
of TCPC, one first needs to quantitatively describe the geom-
etry of the TCPC anatomy to examine whether changes in
the TCPC geometry produce significant changes in the net
resistance or energy losses and thus significant changes in
cardiac output,. Previous studies have shown that certain
geometric characteristics of the TCPC and the associated
vessels, mainly the pulmonary arteries (PAs), play an impor-
tant role in determining the short-term and long-term patient
outcome8,10-12 In vitro studies have highlighted the impor-
tance of curvature of the inferior vena cava (IVC) and its off-
set relative to the superior vena cava (SVC) in minimizing
the energy dissipation at idealized TCPC junctions.7-13 De-
spite these studies, no quantitative data exist that character-
ize the complex TCPC geometries of patients and correlate
their hemodynamic efficiency/inefficiency with geometric
parameters. Furthermore, no studies exist that correlate ana-
tomic or hemodynamic characteristics of the TCPC to pa-
tient cardiac performance (eg, cardiac index).
Our most recent study has quantitatively characterized the
geometries of patient-specific EC and LT TCPCs.14 The
present paper is a retrospective analysis in which we com-
pare the geometric findings with in vitro and in vivo hemo-
dynamic parameters of patient-specific Fontan anatomies to
identify which geometric parameters are most important.rgery c March 2009
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DAbbreviations and Acronyms
BSA ¼ body surface area
CFD ¼ computational fluid dynamics
CHOA ¼ Children’s Healthcare of Atlanta
CHOP ¼ Children’s Hospital of Philadelphia
EC ¼ extracardiac
IVC ¼ inferior vena cava
LPA ¼ left pulmonary artery
LT ¼ lateral tunnel
MRI ¼ magnetic resonance imaging
PA ¼ pulmonary artery
RPA ¼ right pulmonary artery
SVC ¼ superior vena cava
TCPC ¼ total cavopulmonary connection
METHODS
We retrospectively studied 22 Fontan patients, 11 each with an EC and
LT TCPC, from an existing magnetic resonance imaging (MRI) database.
All patients were imaged either at Children’s Healthcare of Atlanta, Egles-
ton Hospital, Atlanta (CHOA), or Children’s Hospital of Philadelphia
(CHOP). Informed consent was obtained from all patients and all study pro-
tocols complied with the institutional review boards of participating hospi-
tals and the Georgia Institute of Technology. Among the 11 EC patients, 2
were from CHOA and 9 from CHOP; among the LT patients, 3 were from
CHOA and 8 from CHOP. The inclusion criteria for this retrospective study
were (1) availability of experimental or computational fluid dynamics
(CFD) power loss quantification of the TCPC or in vivo cardiac output in-
formation; (2) availability of clinical information necessary to categorize
each study group; and (3) the anatomic reconstruction with no visible arti-
facts (some geometries have loss of MRI signal owing to the presence of
surgical clips).
For all 22 patients, geometric characterization of the TCPC was per-
formed to quantitatively differentiate EC and LT as described previously.14
In vitro energy loss quantification for 6 of 22 patients (3 each of EC and LT
types) and CFD simulation of energy loss for 9 of the 22 patients for resting
cardiac output and equal PA flow split was available.9,15 Clinical details of
the entire patient population are shown in Table 1.
Geometric Characterization
To characterize the complex 3-dimensional geometries of the TCPCs, we
used a skeletonization approach, which is commonly used for shape analysis
applications. In brief, the full 3-dimensional TCPC anatomy is first recon-
structed from the raw stack of MRI data and represented as a triangulated
3-dimensional surface geometry.16,17 The patient-specific surface represen-
tation is then used to obtain the respective skeletal representation of the anat-
omy using the skeletonization approach, where each vessel is reduced to its
centerline curve, as described below (see previous article for full details14):
The 3-dimensional surface representation of the TCPC was sliced at
approximately 1-mm spacing in theMRI left–right and superior–inferior co-
ordinate directions, thus generating sections that were roughly perpendicu-
lar to the left and right PAs (LPA and RPA) and IVC and SVC, respectively.
The centroids of these cross sections were computed and connected to gen-
erate an initial estimate of the vessel centerline. Inasmuch as this approxima-
tion was poor in regions where the sectioning significantly departs from the
true normal to the vessel, the centerline was iteratively refined as follows:
For each subsequent iteration, the 3-dimensional vessel geometry was re-
sliced in a direction perpendicular to the tangent of the centerline curve.
The centroids were recomputed for the new slices and the curve throughThe Journal of Thoracic andthe newly computed centroids provided a better estimate of the true center-
line. Cross-sectional areas of the IVC, SVC, LPA, and RPA were also com-
puted as a part of this process. All vessel areas were normalized with patient
body surface area.
Energy Loss
Energy dissipation rate or power loss in the TCPC was available from
both in vitro measurements and CFD simulations at 50:50 pulmonary
flow split, and resting cardiac output conditions as detailed below. The
boundary conditions for both modalities (in vitro and CFD) are the same
and therefore justify the use of both the available datasets together.
In vitro. Anatomically accurate in vitro models of 6 of the 24 recon-
structed patient TCPCs (3 EC and 3 LT) were fabricated by stereolithogra-
phy.18 Each in vitromodel was inserted in a flow loop, which allowed for the
control of the total cardiac output as well as IVC/SVC and LPA/RPA flow
splits. Global flow rates and static pressures measurements were acquired at
each inlet and outlet. These static pressures were corrected for pressure head
bias introduced by small changes in the model elevation and then used to
compute power losses ( _Eloss) across the connection using an integrated, con-
trol volume energy balance equation6
_Eloss ¼
X
Inlets
Pi,Qi
X
Outlets
Pi,Qi (1)
where Pi andQi, are the total pressures (ie, includes static and dynamic) and
volumetric flow rate, respectively. The energy loss was experimentally de-
termined for the resting flow conditions shown in Table 2.
CFD. For CFD simulations, the vessel volumes were discretized into
computational elements (meshes). The number of elements varied, depend-
ing on geometry size and complexity, but ranged from 548,842 to 1,674,440
for the models studied.9 At each element, the governing Navier–Stokes con-
servation equations of mass and momentum for laminar fluid flow were
solved. The CFD computations were performed with the commercial soft-
ware FIDAP 8.7.4 (Ansys Inc, Canonsburg, Pa). Power loss through the
TCPC was calculated by the control volume method (same as equation 1).
Cardiac Index
The resting cardiac output of each patient calculated from the phase-con-
trast MRI scan was indexed to the patient body surface area (BSA) to obtain
cardiac index.
Energy Loss Nondimensionalization
So that geometric and hemodynamic features for different patients can be
compared, the power loss is nondimensionalized using the dynamic power
of the circulation:
e0 ¼ r Q
3
BSA2
(2)
where r is the density of blood, Q is the flow rate, and BSA is the body sur-
face area. The TCPC energy dissipation index, computed as e normalized
with e0, is the proper indexed resistance measure of the TCPC. Normalizing
to dynamic power has been described in the clinical literature before,19 with
resulting resistance coefficient consistent with the well-established engi-
neering methodology that is used to compare resistances of complex pipe
networks and fittings.20,21 Also note that the PA flow split is held constant
at 50:50 for all patient geometries to truly determine the resistance (cost) to
drive an ideal flow condition. This eliminates the bias owing to varying lung
resistances from patient to patient when using in vivo flow split.
Statistical Analysis
Inasmuch as all comparative data were found to be non-normal and to
correspond to a 2-sample population (EC vs LT), the nonparametricCardiovascular Surgery c Volume 137, Number 3 561
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DMann–Whitney test was used to examine statistical significance among the
various geometric parameters evaluated. Differentiating factors are consid-
ered statistically significant for P values<.05. Standard regression analysis
was performed to examine statistically significant association between ana-
tomic and hemodynamic parameters.
RESULTS
Figure 1 shows the normalized mean vessel cross-sec-
tional areas computed for IVC baffle, SVC, LPA, and
TABLE 1. Clinical diagnosis of patients with EC andLTFontan repair
Patient Diagnosis Hemi/BDG BSA (m2) Age (y)
EC TCPC
1 HLHS BDG 0.79 6
2 HRV, TA BDG 0.69 5
3 HLHS Hemi 1.05 10
4 HRV, Ebstein anomaly BDG 1.02 8
5 DILV, PS, TGA BDG 1.064 9
6 DX, TA, TGA, AA
hypoplasia
BDG 0.544 3
7 TA, VSD BDG 0.872 7
8 Pulmonary atresia, IVS,
RV hypertrophy
BDG 1.152 8
9 DORV, IVS, MA,
pulmonary atresia
BDG 0.994 8
10 DILV, pulmonary atresia BDG 1.253 8
11 Ebstein anomaly BDG 0.793 8
LT TCPC
12 HRV, TA, VSD, PS BDG 0.56 3
13 SV-DI AV connection BDG 0.58 2
14 HLHS BDG 1.21 11
15 HLHS Hemi 1.94 16
16 HLHS Hemi 1.23 12
17 TA, VSD Hemi 1.32 10
18 HRV, DX, TA, VSD, PS Hemi 1.19 11
19 Pulmonary atresia, HRV Hemi 1.49 15
20 HLHS Hemi 0.963 9
21 HLHS, TGA, hypoplastic
AA, VSD
Hemi 0.495 1
22 PA BDG 1.063 10
EC, Extracardiac; LT, lateral tunnel; BDG, bidirectional Glenn; BSA, body surface
area; TCPC, total cavopulmonary connection; HLHS, hypoplastic left heart syndrome;
HRV, hypoplastic right ventricle; DILV, double-inlet left ventricle; PS, pulmonary
stenosis; TGA, transposition of the great arteries;DX, TA, tricuspid atresia; AA, ascend-
ing aorta; VSD, ventricular septal defect; IVS, interventricular septum; RV, right ven-
tricle; DORV, double-outlet right ventricle; MA, mitral atresia; SV-DI, double-inlet
single ventricle; AV, atrioventricular; DX, dextrocardia.
TABLE 2. Flow conditions used in the evaluation of power loss using
in vitro experiments
Patient Flow conditions (L/min)
EC 1 2
EC 2 2
EC 5 2
LT 2 2
LT 3 4
LT 7 4
EC, Extracardiac; LT, lateral tunnel.562 The Journal of Thoracic and Cardiovascular SurRPA of both the EC and LT patient populations. The IVC
baffle was between 3.5 and 4 cm2/m2 for both EC and LT,
and the SVC, RPA, and LPA were all between 1 and 2
cm2/m2. Figure 2 shows the minimum cross-sectional area
of the PA for EC and LT patients. The magnitude was about
0.45 cm2/m2 irrespective of EC or LT connection type. Sta-
tistical comparison of the vessel cross-sectional areas and
minimum areas of the PAs has been tabulated in Table 3
with no statistically significant difference in the vessel size
characteristics between the LT and EC groups.
Figure 3 shows the plot of the in vitro and the CFD TCPC
energy dissipation index, for 50:50 pulmonary flow split and
resting cardiac output, as a function of the smaller of the
minimum cross-sectional areas of the two PAs. A power
law fit produced an R2 of 0.898 and a P value of .0002.
Figure 4 shows the plot of patient resting cardiac index
again using the minimum cross-sectional area between the
two PAs. The cardiac index of the patients varied between
FIGURE 1. Mean cross-sectional areas of each vessel in the vicinity of the
TCPC compared between EC and LT patient groups (n ¼ 11 each). IVC,
Inferior vena cava; SVC, superior vena cava; RPA, right pulmonary artery;
LPA, left pulmonary artery; BSA, body surface area.
FIGURE 2. Minimum cross-sectional areas computed between the TCPC
outlet vessels left and right pulmonary arteries for EC and LT patient groups
(n ¼ 11 each). PA, Pulmonary artery; BSA, body surface area.gery c March 2009
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D2 and 3.5 with a significant statistical association (P¼ .006).
A linear fit provided an R2 of 0.32.
DISCUSSION
This is a retrospective study in which we address the ques-
tion: do the anatomic characteristics of the TCPC affect its
hydrodynamic efficiency and, more importantly, the patient
cardiac output, and if so what characteristics of the TCPC
geometry significantly matter?
First, as shown in Figures 1 and 2, there exist no signifi-
cant differences between EC and LT TCPCs when consider-
ing sizes of the vessels even though EC and LT TCPCs are
a result of significantly different surgical approaches for
constructing the Fontan baffle. In our recent study,14 we an-
alyzed other geometric parameters such as curvatures, off-
sets, and vessel area variance. None of these parameters
was significantly different except for the vessel area varia-
tion, where LT TCPCs had a larger area variation in the
IVC baffle owing to the presence of right atrial wall as
part of the baffle. However, as discussed below, the most
significant geometric parameter that influences the hemody-
namic efficiency of the connection is the minimum vessel
cross-sectional area of the PAs.
Figure 3 clearly indicates that the TCPCenergy dissipation
index drops as a power law decay with increasing minimum
PA size (P ¼ .0002). Such a strong correlation (R2¼ 0.898)
with minimum PA size even with a significant difference
between EC and LT IVC baffle area variance and the large
patient–to-patient variability in other parameters such as cur-
vature,14 offsets, et cetera, demonstrates that the minimum
PA size far dominates influence from any other geometric
parameter. From a fluid mechanics standpoint, the TCPC
may thus be viewed as a ‘‘sudden contraction’’ fitting where
flow from larger vessels (IVC and SVC) are routed to the rel-
atively smaller PAs. The results are indeed analogous to that
for the sudden pipe contraction problem in which it is known
that the inlet and outlet sizes primarily define the energy loss.
From the results presented in Figure 4, cardiac index
linearly increases with smallest cross section of the PA
(P ¼ .002). This increase in resting cardiac output may be
attributed to the reduced TCPC energy dissipation index.
However, note that the R2 of 0.32 shows that there exists
a significant scatter that is visually well distributed on either
side of the linear fit line (see Figure 4). These variations may
be attributed to the varying single ventricle pump charact-
eristics from patient to patient that depend on the precise
nature of the congenital heart defect. Nevertheless, from
these data it is clear that the minimum cross-sectional size
of the PA plays a statistically significant role in determining
the TCPC energy loss and thus resting cardiac output of
Fontan patients. This impact is postulated to become even
stronger under exercise conditions, as recently suggested
by another study9 in which resistance of the TCPC nonli-
nearly increased with exercise and in some cases surpassed
the lung resistance.
FIGURE 3. Normalized TCPC power loss e=e0 obtained from in vitro
experiments and CFD simulations computed at the physiologic conditions
plotted against the minimum cross-sectional areas of the pulmonary arteries
(PA). BSA, Body surface area.
FIGURE 4. Normalized minimum cross-sectional areas of the pulmonary
arteries (PA) plotted against the patient cardiac index. BSA, Body surface
area.
TABLE 3. Vessel areas (in cm2/m2) computed for extracardiac and
lateral tunnel groups
Computed
variables EC LT P value
Mean vessel
area
IVC 3.51E-04  1.82E-04 3.83E-04  1.62E-04 .2917
SVC 1.65E-04  0.71E-04 1.23E-04  0.51E-04 .0874
RPA 1.11E-04  0.70E-04 1.06E-04  0.43E-04 .2917
LPA 1.03E-04  0.52E-04 0.88E-04  0.34E-04 .1704
Minimum
vessel area
RPA 7.5E-5  5.97E-5 6.75E-5  3.2E-5 .3537
LPA 5.73E-5  3.67E-5 4.12E-5  2.09E-5 .1183
PA 4.54E-5  3.84E-5 4.30E-5  2.79E-5 .3754
EC, Extracardiac; LT, lateral tunnel; IVC, inferior vena cava; SVC, superior vena cava;
RPA, right pulmonary artery; LPA, left pulmonary artery; PA, pulmonary artery.The Journal of Thoracic and Cardiovascular Surgery c Volume 137, Number 3 563
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DClinical Significance
In this study, we show that the vessel sizes of TCPC (par-
ticularly that of the PAs) plays a significant role in determin-
ing the TCPC performance and the resting cardiac output
and all other geometric characteristics having a lower im-
pact. This significant role of the PA characteristic on the pa-
tient resting cardiac output, regardless of EC or LT, does not
imply that the TCPC efficiency between EC and LT are the
same. It only implies that outlet characteristics have a stron-
ger impact on TCPC energy loss than any difference that
may be present between EC and LT, including the shapes
and orientation of the anastomosis. Also, this suggests that
comparisons between EC and LT resistance are meaningful
only if the normalized energy dissipation is further indexed
to the variation with respect to minimum PA size.
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